Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EstAMR

Financiado

Cerrado

Estimating the Prevalence of AntiMicrobial Resistance

Antimicrobial resistance (AMR) is the ability of an infection to stop antimicrobials, such as antibiotics, antivirals and antimalarials, from working against it. In the EU, every year AMR is responsible for thousands of deaths and... ver más

31/07/2022

SWISS TPH SWISS TR...

203K€

Presupuesto del proyecto: 203K€

Líder del proyecto

SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INST... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-07-31

MSCA-IF-2018: Individual Fellowships

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

SWISS TPH SWISS TROPICAL AND...

203.15K€ | Lider

Proyectos interesantes

RYC2021-031613-I

Medical Technol...

Data Science

236K€ Cerrado

SchiSTOP

Medical Technol...

Data Science

176K€ Cerrado

COMPLEXDYNAMICS-PHIM

Medical Technol...

Data Science

180K€ Cerrado

TBornotTB

Medical Technol...

Data Science

1M€ Cerrado

MALARES

Medical Technol...

Data Science

1M€ Cerrado

MIDIDP

Medical Technol...

Data Science

158K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 39 meses Fecha Inicio: 2019-04-15
Fecha Fin: 2022-07-31

Líder del proyecto

SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INST... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 203K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Antimicrobial resistance (AMR) is the ability of an infection to stop antimicrobials, such as antibiotics, antivirals and antimalarials, from working against it. In the EU, every year AMR is responsible for thousands of deaths and costs millions of euros. Yet forecasting the prevalence of AMR remains an open challenge. This project meets this challenge by developing cutting-edge Hierarchical Bayesian models (HBMs). As a case study, the models will focus on the malaria parasite Plasmodium falciparum that has developed resistance to sulfadoxine/pyrimethamine between 1994 and 2016. This ensures that the goals are realistic, with immediate insight and impact, whilst also remaining methodologically relevant for all AMR. Within the field of ecology, regression models are being replaced so as to incorporate more complex non-linear relationships between abundance and the environment. Unlike traditional methods, HBMs are spatiotemporal models that (i) account for varying geography (ii) separate underlying processes and (iii) include uncertainty in the data and model parameters. This thorough package has proven to yield more insight and accuracy. By using partial differential equations, HBMs separate occurrence due to spread and occurrence due to emergence. Despite its relevance, differentiating between these two process is currently unexplored in epidemiology. Furthermore, when modelling AMR, infections competing for hosts is a process which is currently unexplored in HBMs. Thus, the two long term contributions of this project are: Bringing HBMs to epidemiology to gain a better understanding of underlying processes, and advancing the field of HBMs to include more complex dynamics. And more immediately, the two key contributions are: Quantifying the dynamics and influencers of the spread of drug resistant malaria, and forecasting the frequency of partially drug resistant malaria, and fully drug resistant malaria, at different locations and at different times.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores